These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 9772674)
1. Reduction of doxorubicin resistance by tetrandrine and dauricine in harringtonine-resistant human leukemia (HL60) cells. He QY; Meng FH; Zhang HQ Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):179-81. PubMed ID: 9772674 [TBL] [Abstract][Full Text] [Related]
2. Resistance to apoptosis of harringtonine-resistant HL60 cells induced by tetrandrine. He QY; Zhang HQ; Pang DB; Chi XS; Xue SB Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):545-9. PubMed ID: 9863153 [TBL] [Abstract][Full Text] [Related]
3. Characteristics of harringtonine-resistant human leukemia HL60 cell. He QY; Zhou WD; Ji L; Zhang HQ; He NG; Xue SB Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):463-7. PubMed ID: 9863176 [TBL] [Abstract][Full Text] [Related]
4. Reversal of doxorubicin resistance by tetrandrine in Chinese hamster ovary cell line. He QY; Jiang B; Zhang HQ; Xue SB Zhongguo Yao Li Xue Bao; 1992 Sep; 13(5):416-9. PubMed ID: 1300043 [TBL] [Abstract][Full Text] [Related]
5. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. Liu ZL; Hirano T; Tanaka S; Onda K; Oka K J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364 [TBL] [Abstract][Full Text] [Related]
6. The ability of selected pyridinium salts to increase the cytotoxic activity of vincristine but not doxorubicin towards sensitive and multidrug resistant promyelocytic leukaemia HL60 cells. Maruszewska A; Kostrzewa-Nowak D; Adamus J; CzupryĆska K; Maryniak D; Gebicki J; Tarasiuk J J Pharm Pharmacol; 2008 May; 60(5):647-53. PubMed ID: 18416942 [TBL] [Abstract][Full Text] [Related]
7. [Poteintation of vincristine-induced apoptosis by tetrandrine, neferine and dauricine in the human mammary MCF-7 multidrug-resistant cells]. Ye ZG; Wang JH; Sun AX; Liang AH; Xue BY; Li CY; Wang L Yao Xue Xue Bao; 2001 Feb; 36(2):96-9. PubMed ID: 12579872 [TBL] [Abstract][Full Text] [Related]
8. Synergistic anticancer effects of tetrandrine combined with doxorubicin or vincristine in vitro. Sun AX; Ye ZG; Li CY; Xue BY; Li LF; Cao XF; Yang Q; Dai BQ Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):69-73. PubMed ID: 10437129 [TBL] [Abstract][Full Text] [Related]
9. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells. Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653 [TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine. Jin J; Wang FP; Wei H; Liu G Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274 [TBL] [Abstract][Full Text] [Related]
11. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
12. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Xu HB; Li L; Liu GQ Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169 [TBL] [Abstract][Full Text] [Related]
13. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier. He L; Liu GQ Acta Pharmacol Sin; 2002 May; 23(5):423-9. PubMed ID: 11978192 [TBL] [Abstract][Full Text] [Related]
14. Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells. Meschini S; Marra M; Condello M; Calcabrini A; Federici E; Dupuis ML; Cianfriglia M; Arancia G Int J Oncol; 2005 Dec; 27(6):1597-603. PubMed ID: 16273216 [TBL] [Abstract][Full Text] [Related]
15. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells. Ganapathi R; Grabowski D; Rouse W; Riegler F Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165 [TBL] [Abstract][Full Text] [Related]
16. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance. Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379 [TBL] [Abstract][Full Text] [Related]
17. Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole. Desai PB; Duan J; Sridhar R; Damle BD Methods Find Exp Clin Pharmacol; 1997 May; 19(4):231-9. PubMed ID: 9228648 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476 [TBL] [Abstract][Full Text] [Related]
19. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines. Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658 [TBL] [Abstract][Full Text] [Related]
20. [Reversal of anti-apoptotic action by tetrandrine in human breast carcinoma multidrug-resistant MCF-7 cells]. Wang JH; Ye ZG; Sun AX; Xue BY; Liang AH; Li CY; Wang L Zhongguo Zhong Yao Za Zhi; 2002 Jan; 27(1):46-50. PubMed ID: 12774357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]